RxDoctor Payments Data

Darian Wilson

Podiatrist · West Reading, PANPI 1699392761

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Stryker at 43.6% of the total. Reporting peaked in 2022 at $4,766 and has fallen 65.6% since, to $1,641 in 2025. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,884in general payments, 2019–2025

Across 128 payments — averaging $100.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Novus Surgical Solutions LLC$2K
  • Treace Medical Concepts, Inc.$1K
  • Linvatec Corporation$950
  • Medical Device Business Services, Inc.$476
  • Integra Lifesciences Corporation$441
  • plus $3K from 27 others

What the payments were for

  • Travel & lodging$4,31433%
  • Food & beverage$7,37057%
  • Education$1,2009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,884 in reported general payments places this provider in the 95th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$198,253
Medicare patients
263
Services billed
1,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate27$660
Clotrimazole22$419
Ciclopirox16$389
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$299
Terbinafine Hcl21$264
Mupirocin22$193
Doxycycline Hyclate21$158
Methylprednisolone17$99
Meloxicam53$93
Gabapentin14$74
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$36

Paid to pharmacies, not to this prescriber.

Other podiatrist in West Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →